Baxter India Gets CDSCO Nod for Use of Its Oxiris Filter in
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Healthcare firm Baxter India on Tuesday (7 July) said it has received approval from the Central Drugs Standard Control Organisation (CDSCO) for the use of its Oxiris blood purification filter for the treatment of COVID-19 patients.

• Filter is intended to be used in the critically ill COVID-19 patients in need of blood purification where excessive inflammatory mediators are present, Baxter India said in a statement.

• During blood purification therapy, the patient’s blood passes through the Oxiris filter set, where it can adsorb inflammatory mediators, and remove fluid, electrolytes and uremic toxins, before returning the patient’s blood to the body.

• Making it the only filter set that does not necessitate the use of additional devices renal replacement therapy or removal of troublesome inflammatory cytokines.

• Oxiris is currently in use across countries in Europe and Asia and has been used for more than 10 years to treat thousands of patients.

Source: https://health.economictimes.indiatimes.com/news/pharma/baxter-india-gets-cdsco-approval-for-its-oxiris-filter-for-covid-19-treatment/76849138
Dr. T●●●●z H●●●●●●i and 7 others like this5 shares
Like
Comment
Share